Related references
Note: Only part of the references are listed.Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4+ T cells
Shailesh K. Choudhary et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Inhibition of HIV fusion with multivalent gold nanoparticles
Mary-Catherine Bowman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency
Richard Pearson et al.
JOURNAL OF VIROLOGY (2008)
Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1
Brandon F. Keele et al.
JOURNAL OF VIROLOGY (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV
Paul A. Wender et al.
SCIENCE (2008)
Rapid and durable Antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection - Results of a 48-week controlled study
Martin Markowitz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Transient viremia, plasma viral load, and reservoir replenishment in HIV-Infected patients on antiretroviral therapy
Laura E. Jones et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo
Philip J. Ellery et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s
Daniel R. Kuritzkes et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
Paul A. Marks et al.
NATURE BIOTECHNOLOGY (2007)
Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques
Paul E. Kennedy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells
Tzu-Ling Sung et al.
RETROVIROLOGY (2006)
Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation
Nanhai He et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces tat-independent HIV-1 expression but blunts cell activation
V Klichko et al.
JOURNAL OF VIROLOGY (2006)
Rapid expression of human immunodeficiency virus following activation of latently infected cells
PA Arlen et al.
JOURNAL OF VIROLOGY (2006)
HIV-1 dynamics at different time scales under antiretroviral therapy
JA García et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Tat gets the green light on transcription initiation
J Brady et al.
RETROVIROLOGY (2005)
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli
WJ Swiggard et al.
JOURNAL OF VIROLOGY (2005)
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir
TW Chun et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Perils at mucosal front lines for HIV and SIV and their hosts
AT Haase
NATURE REVIEWS IMMUNOLOGY (2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor Ligation requires both PKCα and PKCθ
SA Trushin et al.
JOURNAL OF VIROLOGY (2005)
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
JA Kovacs et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus
S Kramer-Hämmerle et al.
VIRUS RESEARCH (2005)
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
LS Weinberger et al.
CELL (2005)
In vivo expansion of CD4+CD45RO-CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients
I Sereti et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
MC Strain et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Host factors regulating post-integration latency of HIV
SAF Williams et al.
TRENDS IN MICROBIOLOGY (2005)
Persistence of replication-competent HIV in the central nervous system despite long-term effective highly active antiretroviral therapy
O Lambotte et al.
AIDS (2005)
IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART
FX Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents
J Kulkosky et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Can HIV be cured? Mechanisms of HIV persistence and strategies to combat it
DH Hamer
CURRENT HIV RESEARCH (2004)
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
JM Brenchley et al.
JOURNAL OF VIROLOGY (2004)
Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs:: implications for the development of therapeutic strategies
D Demonté et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Interleukin-7 induces HIV type 1 outgrowth from peripheral resting CD4+ T cells
G Lehrman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
An update on the neuropathology of HIV in the HAART era
JE Bell
HISTOPATHOLOGY (2004)
A long-term latent reservoir for HIV-1: discovery and clinical implications
JD Siliciano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors
L Ylisastigui et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
L Ylisastigui et al.
AIDS (2004)
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue
A Biancotto et al.
JOURNAL OF VIROLOGY (2004)
Importance and detection of virus reservoirs and compartments of HIV infection
DC Nickle et al.
CURRENT OPINION IN MICROBIOLOGY (2003)
HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection
S Swingler et al.
NATURE (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen
MA Polis et al.
AIDS (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:: Intrinsic stability predicts lifelong persistence
MC Strain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Determining the relative efficacy of highly active antiretroviral therapy
M Louie et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Reservoirs, sanctuaries, and residual disease: The hiding spots of HIV-1
RJ Pomerantz
HIV CLINICAL TRIALS (2003)
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Peripheral blood dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART
M Otero et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides
JJ Coull et al.
JOURNAL OF VIROLOGY (2002)
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy
J Kulkosky et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection
V Müller et al.
JOURNAL OF VIROLOGY (2002)
Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes
O Ducrey-Rundquist et al.
JOURNAL OF VIROLOGY (2002)
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
HJ Stellbrink et al.
AIDS (2002)
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy
D Marras et al.
NATURE MEDICINE (2002)
Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment
WS Hlavacek et al.
MATHEMATICAL BIOSCIENCES (2002)
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections
G Nunnari et al.
AIDS (2002)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection
M Dybul et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy
TF Zhu et al.
JOURNAL OF VIROLOGY (2002)
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
MA Polis et al.
LANCET (2001)
Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART
J Kulkosky et al.
BLOOD (2001)
Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals
A Llano et al.
JOURNAL OF VIROLOGY (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection
JA Winston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
RME Van Praag et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Generation of HIV latency during thymopoiesis
DG Brooks et al.
NATURE MEDICINE (2001)
Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
S Sonza et al.
AIDS (2001)
Increased production of IL-7 accompanies HIV-l-mediated T-cell depletion: implications for T-cell homeostasis
LA Napolitano et al.
NATURE MEDICINE (2001)
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy
WS Hlavacek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
TW Chun et al.
NATURE MEDICINE (2000)
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
TBH Geijtenbeek et al.
CELL (2000)
Share Paper
